Pendal Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-30,720
Closed -$3.05M 530
2019
Q3
$3.05M Hold
30,720
0.04% 163
2019
Q2
$2.84M Sell
30,720
-2,398
-7% -$228K 0.04% 176
2019
Q1
$3.12M Sell
33,118
-144,458
-81% -$12.6M 0.04% 171
2018
Q4
$11.4M Buy
177,576
+129,417
+269% +$9.55M 0.18% 79
2018
Q3
$4.31M Buy
48,159
+39,864
+481% +$3.52M 0.06% 147
2018
Q2
$659K Sell
8,295
-185,941
-96% -$15.4M 0.01% 348
2018
Q1
$17.3M Buy
194,236
+52,823
+37% +$5.07M 0.22% 67
2017
Q4
$14.8M Buy
141,413
+90,120
+176% +$10.2M 0.19% 89
2017
Q3
$7.48M Buy
51,293
+7,985
+18% +$1.09M 0.1% 143
2017
Q2
$5.62M Buy
+43,308
New +$5.31M 0.08% 160

Other funds holding CELG

Pendal Group's CELG Position: Q4 2019 in Review

Pendal Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 30,720 shares — an estimated $3.05M sold.

Pendal Group first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $17.3M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pendal Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pendal Group sold 30,720 Celgene Corp shares in Q4 2019, an estimated $3.05M.
  • Pendal Group first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Pendal Group's Celgene Corp position peaked at $17.3M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pendal Group's 13F filing for Q4 2019, filed 6 Feb 2020.